Genesys International Corp Intrinsic Value

Genesys International Corp (GENESYS) median intrinsic value is ₹164.57 from 9 valuation models (range ₹89–₹434), vs current price ₹297.70 — -44.7% downside (Trading Above Calculated Value), margin of safety -80.9%. For current market price and key ratios, visit Genesys International Corp share price today.

Current Stock Price
₹297.70
Primary Intrinsic Value
₹145.92
Market Cap
₹625.2 Cr
-44.7% Downside
Median Value
₹164.57
Value Range
₹89 - ₹434
Assessment
Trading Above Calculated Value
Safety Margin
-80.9%

GENESYS Valuation Methods Summary — DCF, Graham Number & P/E

Genesys International Corp intrinsic value across 9 models vs current price ₹297.70 — upside/downside and value range per method. Read GENESYS dividend track record for the complete payout history and dividend yield track record.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹145.92 ₹116.74 - ₹175.10 -51.0% EPS: ₹12.16, Sector P/E: 12x
Book Value Method asset ₹335.24 ₹301.72 - ₹368.76 +12.6% Book Value/Share: ₹335.24, P/B: 1.0x
Revenue Multiple Method revenue ₹164.57 ₹148.11 - ₹181.03 -44.7% Revenue/Share: ₹205.71, P/S: 0.8x
EBITDA Multiple Method earnings ₹434.29 ₹390.86 - ₹477.72 +45.9% EBITDA: ₹152.00Cr, EV/EBITDA: 6x
Simple DCF (5Y) dcf ₹119.08 ₹95.26 - ₹142.90 -60.0% CF Growth: 5.0%, Discount: 15%
PEG Ratio Method growth ₹89.31 ₹80.38 - ₹98.24 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹100.20 ₹90.18 - ₹110.22 -66.3% Revenue Growth: 6.0%, Adj P/E: 8.2x
ROE Based Valuation profitability ₹247.62 ₹222.86 - ₹272.38 -16.8% ROE: 7.4%, P/E Multiple: 10x
Graham Defensive Method conservative ₹302.85 ₹272.57 - ₹333.14 +1.7% EPS: ₹12.16, BVPS: ₹335.24
Method Types: Earnings Asset DCF Growth Dividend Conservative

GENESYS Intrinsic Value vs Market Price — All Valuation Models

Genesys International Corp fair value range ₹89–₹434 vs current market price ₹297.70 across 9 valuation models. Analyse GENESYS shareholder distribution to track promoter, FII and institutional holdings.

GENESYS Intrinsic Value Analysis — Undervalued or Overvalued?

Genesys International Corp median intrinsic value ₹164.57, current price ₹297.70 — Trading Above Calculated Value by 44.7%, margin of safety -80.9%.

What is the intrinsic value of GENESYS?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Genesys International Corp (GENESYS) is ₹164.57 (median value). With the current market price of ₹297.70, this represents a -44.7% variance from our estimated fair value.

The valuation range spans from ₹89.31 to ₹434.29, indicating ₹89.31 - ₹434.29.

Is GENESYS undervalued or overvalued?

Based on our multi-method analysis, Genesys International Corp (GENESYS) appears to be trading above calculated value by approximately 44.7%.

GENESYS Financial Health — Key Ratios vs Industry Benchmarks

Genesys International Corp financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 25.24 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Return on Equity 7.4% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency
Operating Margin 33.0% Industry Standard: 20%+ Above 20% Indicates operational efficiency level
Asset Turnover Ratio 0.44x Industry Standard: 1.0x+ Below 0.5x Measures asset utilization efficiency

GENESYS Cash Flow Quality — Operating & Free Cash Flow

Genesys International Corp operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹-53 Cr ₹-62 Cr Negative Cash Flow 3/10
March 2024 ₹19 Cr ₹-21 Cr Positive Operating Cash Flow 6/10
March 2023 ₹-35 Cr ₹-130 Cr Negative Cash Flow 3/10
March 2022 ₹28 Cr ₹18 Cr Positive Free Cash Flow 8/10
March 2021 ₹19 Cr ₹13 Cr Positive Free Cash Flow 8/10